Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy CSL (CSL) shares

Learn how to easily invest in CSL shares.

CSL Ltd (CSL) is a leading biotechnology business based in Australia. It opened the day at AUDA$292.6 after a previous close of AUDA$292.5. During the day the price has varied from a low of AUDA$291.95 to a high of AUDA$301.55. The latest price was AUDA$299.34 (25 minute delay). CSL is listed on the Australian Securities Exchange (ASX) and employs 25,000 staff. All prices are listed in Australian Dollars.

How to buy shares in CSL

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CSL – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Compare trading platforms with Australian shares and ETFs

Name Product Available Investment Types Min. Monthly Fee Available Markets
OFFER
BlackBull Markets Share Trading
Shares
$0
US, NZ, AU, Funds with exposure to multiple markets
Exclusive: Sign up through Finder and get 5 free shares with a minimum first time deposit of $1,000. T&Cs apply.
Trade 23,000+ shares and access 80+ global markets across the US, New Zealand, Australia and more, plus benefit from extended trading hours, no monthly fees, 24/6 dedicated local support and a mobile trading app available on both Android and iOS.
Rockfort Markets Share Trading
Shares
$20
US, AU, Funds with exposure to multiple markets
Trade shares in more than 1000 companies across the US, Australia and more.
Low brokerage on trades, plus access to professional tools, research and live market data. Available on desktop and mobile.
Sharesies
Shares, ETFs, Managed Funds, Index Funds
$0
US, NZ, AU, Funds with exposure to multiple markets
Trade and invest in more than 8,000 companies, ETFs and managed funds across New Zealand, the US and Australia.
OFFER
Tiger Brokers
Shares, ETFs, Options
$0
US, AU, Funds with exposure to multiple markets
Sign up to Tiger Brokers and get a free stock voucher worth NZ$10, plus receive 3 Rocket Lab shares and one lucky draw ticket to win a free share when you deposit at least NZ$500 into your Tiger account. Offer is for new clients only and is subject to minimum deposit requirements. T&Cs apply.
Trade shares in more than 7,000 companies across the US, Australia and Asia.
loading

Compare up to 4 providers

How has Coronavirus impacted CSL's stock price?

Since the stock market crash in March caused by coronavirus, CSL's stock price has had significant negative movement.

Its last market close was A$292.5, which is 13.05% down on its pre-crash value of A$336.4 and 20.53% up on the lowest point reached during the March crash when the stocks fell as low as A$242.67.

If you had bought A$1,000 worth of CSL stocks at the start of February 2020, those stocks would have been worth A$905.99 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth A$938.93.

CSL shares at a glance

Information last updated 2022-08-18.
OpenA$292.60
HighA$301.55
LowA$291.95
CloseA$299.34
Previous closeA$292.50
Change A$6.84
Change % 2.3385%
Volume 582,882
Information last updated 2022-08-15.
52-week rangeA$238.78 - A$318.02
50-day moving average A$282.39
200-day moving average A$277.72
Wall St. target priceA$314.57
PE ratio 41.35
Dividend yield A$2.22 (0.97%)
Earnings per share (TTM) A$7.17

CSL stock price (Australian Securities Exchange (ASX):CSL)

Use our graph to track the performance of CSL stocks over time.

CSL price performance over time

Historical closes compared with the close of A$299.34 from 2022-08-17

1 week (2022-08-10) 2.39%
1 month (2022-07-18) 0.90%
3 months (2022-05-18) 9.61%
6 months (2022-02-18) 12.72%
1 year (2021-08-18) 1.97%
2 years (2020-08-18) 2.06%
3 years (2019-08-16) 31.64%
5 years (2017-08-17) 135.70%

Is CSL under- or over-valued?

Valuing CSL stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CSL's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

CSL's P/E ratio

CSL's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 41x. In other words, CSL shares trade at around 41x recent earnings.

That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

CSL's EBITDA

CSL's EBITDA (earnings before interest, taxes, depreciation and amortisation) is A$3.4 billion.

The EBITDA is a measure of a CSL's overall financial performance and is widely used to measure a its profitability.

CSL financials

Revenue TTM A$10.6 billion
Operating margin TTM 28.31%
Gross profit TTM A$5.8 billion
Return on assets TTM 9.13%
Return on equity TTM 20.96%
Profit margin 21.91%
Book value A$29.31
Market capitalisation A$141.1 billion

TTM: trailing 12 months

CSL's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CSL.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

CSL's total ESG risk score

Total ESG risk: 27.73

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CSL's overall score of 27.73 (as at 01/01/2019) is pretty good – landing it in it in the 40th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like CSL is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

CSL's environmental score

Environmental score: 3.04/100

CSL's environmental score of 3.04 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CSL is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

CSL's social score

Social score: 18.57/100

CSL's social score of 18.57 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CSL is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

CSL's governance score

Governance score: 11.12/100

CSL's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that CSL is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

CSL's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. CSL scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that CSL has, for the most part, managed to keep its nose clean.

CSL share dividends

43%

Dividend payout ratio: 43.25% of net profits

Recently CSL has paid out, on average, around 43.25% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.97% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CSL shareholders could enjoy a 0.97% return on their shares, in the form of dividend payments. In CSL's case, that would currently equate to about A$2.22 per share.

While CSL's payout ratio might seem fairly standard, it's worth remembering that CSL may be investing much of the rest of its net profits in future growth.

The latest dividend was paid out to all shareholders who bought their shares by 7 March 2022 (the "ex-dividend date").

Have CSL's shares ever split?

CSL's shares were split on a 3:1 basis on 18 October 2007. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your CSL shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for CSL shares which in turn could have impacted CSL's share price.

CSL share price volatility

Over the last 12 months, CSL's shares have ranged in value from as little as A$238.7774 up to A$318.0184. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while CSL's is 0.1618. This would suggest that CSL's shares are less volatile than average (for this exchange).

CSL overview

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involve substantial risk of loss and therefore are not appropriate for all investors. Past performance is not an indication of future results. Consider your own circumstances and obtain your own advice before making any trades.

More guides on Finder

Go to site